Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy
- PMID: 23628134
- DOI: 10.1016/j.ijrobp.2013.02.024
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy
Abstract
Purpose: To evaluate outcomes of conservative surgery and radiation therapy (RT) treatment in patients with dermatofibrosarcoma protuberans.
Methods and materials: We retrospectively reviewed the medical records of 53 consecutive dermatofibrosarcoma protuberans patients treated with surgery and preoperative or postoperative radiation therapy between 1972 and 2010. Median tumor size was 4 cm (range, 1-25 cm). Seven patients (13%) were treated with preoperative RT (50-50.4 Gy) and 46 patients (87%) with postoperative RT (60-66 Gy). Of the 46 patients receiving postoperative radiation, 3 (7%) had gross disease, 14 (30%) positive margins, 26 (57%) negative margins, and 3 (7%) uncertain margin status. Radiation dose ranged from 50 to 66 Gy (median dose, 60 Gy).
Results: At a median follow-up time of 6.5 years (range, 0.5 months-23.5 years), 2 patients (4%) had disease recurrence, and 3 patients (6%) had died. Actuarial overall survival was 98% at both 5 and 10 years. Local control was 98% and 93% at 5 and 10 years, respectively. Disease-free survival was 98% and 93% at 5 and 10 years, respectively. The presence of fibrosarcomatous change was not associated with increased risk of local or distant relapse (P=.43). One of the patients with a local recurrence had gross residual disease at the time of RT and despite RT to 65 Gy developed both an in-field recurrence and a nodal and distant recurrence 3 months after RT. The other patient with local recurrence was found to have in-field recurrence 10 years after initial treatment. Thirteen percent of patients had an RT complication at 5 and 10 years, and 9% had a moderate or severe complication at 5 and 10 years.
Conclusions: Dermatofibrosarcoma protuberans is a radioresponsive disease with excellent local control after conservative surgery and radiation therapy. Adjuvant RT should be considered for patients with large or recurrent tumors or when attempts at wide surgical margins would result in significant morbidity.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):395-401. doi: 10.1016/j.bjps.2015.10.027. Epub 2015 Oct 30. J Plast Reconstr Aesthet Surg. 2016. PMID: 26646402
-
Evaluation of the role of radiotherapy in the management of dermatofibrosarcoma protuberans.J BUON. 2013 Jan-Mar;18(1):268-73. J BUON. 2013. PMID: 23613415
-
The role of radiation therapy in the management of dermatofibrosarcoma protuberans.Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):823-7. doi: 10.1016/s0360-3016(97)00895-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531366 Review.
-
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16414206 Clinical Trial.
-
Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review.Anticancer Res. 2010 Sep;30(9):3775-9. Anticancer Res. 2010. PMID: 20944168 Review.
Cited by
-
A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.World J Surg Oncol. 2017 Jan 5;15(1):5. doi: 10.1186/s12957-016-1075-2. World J Surg Oncol. 2017. PMID: 28056985 Free PMC article. Clinical Trial.
-
Dermatofibrosarcoma protuberans of the upper eyelid treated with surface mould high-dose-rate brachytherapy.Rep Pract Oncol Radiother. 2022 Mar 22;27(1):182-187. doi: 10.5603/RPOR.a2021.0110. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 35402039 Free PMC article.
-
Vulvar Dermatofibrosarcoma protuberance in Iran and a narrative review of literature: A first case report.Caspian J Intern Med. 2023 Summer;14(3):572-576. doi: 10.22088/cjim.14.3.572. Caspian J Intern Med. 2023. PMID: 37520865 Free PMC article.
-
Wide local excision, Mohs micrographic surgery, and reconstructive options for treatment of dermatofibrosarcoma protuberans of the breast: A retrospective case series from Mayo Clinic.World J Surg Oncol. 2023 May 6;21(1):141. doi: 10.1186/s12957-023-03022-9. World J Surg Oncol. 2023. PMID: 37147611 Free PMC article.
-
Diagnosis and management of primary malignant tumors in the upper extremity.Orthop Rev (Pavia). 2021 Jan 27;12(4):8345. doi: 10.4081/or.2020.8345. eCollection 2020 Dec 31. Orthop Rev (Pavia). 2021. PMID: 33569156 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical